CLASS II ONGOING Drug recall · Reported 15 Jul 2026 · FDA Enforcement Report
Clomiphene Citrate USP Active Pharmaceutical Ingredient recalled
Shimoga Chemicals is recalling Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), distributed in California, Florida. The recall was initiated on 19 May 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0691-2026
- FDA event ID
- 99232
- Recalling firm
- Shimoga Chemicals, Sangli, N/A
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 19 May 2026
- FDA classified
- 15 Jul 2026
- Reported
- 15 Jul 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
Timeline
| 19 May 2026 | Recall initiated by company | |
| 15 Jul 2026 | Classified by FDA | +57 days |
| 15 Jul 2026 | Published in enforcement report | +0 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP deviations
Product as listed by the FDA
Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), Net Weight a)1 KG (NDC 84849-000-01), b) 500 g (NDC 84849-000-02), (c) 100 g (NDC 84849-000-03), Rx Only, Shimoga Chemicals Address -W-57A, MIDC Kupwad Samgli, Maharashtra, 416436, India.
Where it was distributed
CA & FL only
Questions about this recall
Why was it recalled?
cGMP deviations
Which lots are affected?
Lot #: a) CC/004/24-25, Exp Date September 2029; CC0032526, Exp. Date August 2030 b) CC0442526, Exp. Date Aug 2030; CC/005/24-25, Exp. Date November 2029 c) CC0032526, Exp. Date August 2030; CC/009/24-25, Exp. Date January 2030;CC/005/24-25, Exp. Date November 2029.
Where was it sold?
CA & FL only
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.